v3.26.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (1,752,989) $ (6,572,723) $ (14,712,850) $ (57,702,015)
Net income (loss) from discontinued operations 2,591,239 (1,029,656)    
Net loss from continuing operations (4,344,228) (5,543,067)    
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:        
Allowance for expected credit losses 872,122 246,883 1,029,317 759,782
Depreciation and amortization 1,286,804 1,289,747 2,587,556 1,323,467
Stock-based compensation 643,861 764,036 1,124,519 896,537
Amortization of right-of-use assets 4,959 41,815 66,220 55,459
Loss on issuance of SEPA 145,174 0    
Loss on extinguishment of loan 0 126,125 221,202 645,979
Gain on extinguishment of ELOC     (42,394) 0
Loss on termination of lease     140,709 0
Deferred income taxes     51,814 (1,679,404)
Amortization of discount on note payable     0 7,000
Goodwill impairment charges     0 56,675,210
Shares issued as part of stock grants to vendors     0 98,000
Loss on issuance of financial instruments 0 138,020 668,020 2,513,234
Change in fair value of financial instruments 32,101 1,416,296 1,450,271 (6,176,097)
Gain on extinguishment of financial liabilities (367,809) 0    
Changes in operating assets and liabilities:        
Accounts receivable (861,915) (707,666) (1,833,791) (1,094,190)
Due from related party (10,859) 290,534 227,042 254,378
Prepaids and other current assets (124,520) 53,076 173,163 (202,245)
Encompass Purchase liability     386,082 0
Accounts payable and accrued liabilities 224,968 711,043 4,235,940 (1,446,302)
Deferred revenue     836,671 (414,710)
Due to related parties     0 (210,755)
Operating lease liabilities (4,959) (34,324) (55,224) (92,870)
Net cash used in operating activities - continuing operations (2,504,301) (1,207,482)    
Net cash (used in) provided by operating activities - discontinued operations (1,121,615) 442,388    
Net cash used in operating activities (3,625,916) (765,094) (3,445,733) (5,789,542)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of long-term investments (100,000) 0    
Net cash used in investing activities- continuing operations (100,000) 0    
Net cash used in investing activities- discontinued operations (28,752) (15,466)    
Cash acquired from Business Combination- iDoc     0 29,123
Purchases of fixed assets     (29,928) (55,267)
Net cash used in investing activities (128,752) (15,466) (29,928) (26,144)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Repayment on advances of related party     0 (47,800)
Repayment on Extension Note     0 (335,750)
Payments on Exchange note       (61,429)
Repayment on Additional Bridge Financing     0 (52,680)
Payments on September 2024 Convertible Note       (38,889)
Payments due on acquisition purchase     (44) (5,150)
Proceeds from reverse recapitalization with DHAC     0 1,323,362
Repayment of notes payable (780,290) 0 (148,576) (38,200)
Payment to shareholder 0 (10,000) (10,000) 0
Proceeds from issuance of common stock 0 90,634 1,500,003 0
Proceeds from notes issued during the period 176,750 726,237 1,759,371 0
Proceeds from factoring payable 0 55,665 (179,007) (180,397)
Proceeds from pre-funded warrants, net of issuance costs 984 0 5,519,085 0
Proceeds from convertible notes issued during the period 750,000 0    
Payments on Encompass acquisition liability (50,000) (44)    
Payments on financing lease liability (591,118) (25,000) (25,000)  
Payments on line of credit (348,952) 0    
Net cash (used in) provided by financing activities - continuing operations (842,626) 837,492    
Net cash used in financing activities - discontinued operations 0 (91,452)    
Net cash (used in) provided by financing activities (842,626) 746,040 8,415,832 6,023,067
NET CHANGE IN CASH (4,597,294) (34,520) 4,940,171 207,381
Cash, Beginning of Period 5,051,445 326,115 326,115 118,734
CASH, END OF THE PERIOD 454,151 291,595 5,051,445 326,115
Supplemental disclosure of cash flow information:        
Cash paid for interest expense 418,689 135,205 212,476 111,331
Non-cash investing and financing activities:        
Shares issued     0 325,279
Escrow shares released from stock payable     0 127,710
Shares issued as conversion of debt     0 155,565
Shares issued as payment for March 2025 promissory Note     706,955 0
Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction     0 4,370,000
Shares issued as part of stock grants to vendors     0 625,750
Shares issued on conversion of the Exchange Note     1,739,840 600,000
Preferred shares issued as conversion of VSee debt as contemplated by the business combination transaction     0 220,000
Net liabilities acquired in reverse merger     0 19,359,122
Finance lease payable reclassed from financing activities to accounts payable     0 407,791
Common stock issued on conversion of notes payable 299,348 0    
Common stock issued on conversion of Quantum note 521,721 0    
Common stock issued to settle directors’ compensation payable 60,762 0    
Common stock issued to settle executives’ compensation payable 555,457 0    
Common stock issued to settle employees and consultants’ compensation payable 776,842 0    
Common stock issued as consideration for investment in GoMyRX Inc. 649,800 0    
Common and preferred stock issued to settle accounts payable 1,573,800 0    
IDoc Virtual Telehealth Solutions, Inc        
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:        
Stock-based compensation 13,023 10,238    
Non-cash investing and financing activities:        
Shares issued     0 68,907,052
Shares issued to settled iDoc debt holders     0 228,000
Digital Health Acquisition Corp        
Non-cash investing and financing activities:        
Shares issued as conversion of debt     0 1,268,000
Quantum Convertible Note        
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible debt     0 2,700,000
Non-cash investing and financing activities:        
Shares issued upon conversion     4,936,550 0
September 2024 Convertible Note        
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible debt     0 2,000,000
Non-cash investing and financing activities:        
Shares issued upon conversion     3,823,462 0
Equity Line Of Credit        
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from convertible debt       760,000
Non-cash investing and financing activities:        
Shares issued as conversion of debt     0 79,500
Additional Bridge Notes        
Non-cash investing and financing activities:        
Shares issued as principal payment of notes     0 159,881
Exchange Note        
Non-cash investing and financing activities:        
Shares issued as principal payment of notes     0 1,177,483
Working Capital Funds Advances        
Non-cash investing and financing activities:        
Shares issued upon conversion     0 405,000
Quantum Note Conversion        
Non-cash investing and financing activities:        
Shares issued upon conversion     530,000 0
March 2025 convertible Note        
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:        
Loss on extinguishment of loan     (138,020)  
Non-cash investing and financing activities:        
Shares issued upon conversion     303,053 0
Preferred Shares | IDoc Virtual Telehealth Solutions, Inc        
Non-cash investing and financing activities:        
Shares issued as conversion of debt     0 300,000
Previously Reported        
CASH FLOWS FROM FINANCING ACTIVITIES:        
Cash, Beginning of Period $ 5,266,286 $ 326,115 326,115  
CASH, END OF THE PERIOD     $ 5,266,286 $ 326,115